Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2011-2-17
pubmed:abstractText
Programmed cell death-1 (PD-1) is an inhibitory coreceptor for T lymphocytes that provides feedback inhibition of T cell activation. Although PD-1's expression on T cells is known to be activation dependent, the factors that determine the timing, intensity, and duration of PD-1 expression in immune reactions are not fully understood. To address this question, we performed a fine mapping analysis of a conserved 5'-flanking region of the PD-1 gene and identified a putative IFN stimulation response element, which was responsible for PD-1 transcription in the 2B4.11 T cell line. Consistent with this finding, activation by IFN-? enhanced both the induction and maintenance of PD-1 expression on TCR-engaged primary mouse T cells through an association IFN-responsive factor 9 (IRF9) to the IFN stimulation response element. Furthermore, PD-1 expression on Ag-specific CD8(+) T cells was augmented by IFN-? in vivo. We propose that strong innate inflammatory responses promote primary T cell activation and their differentiation into effector cells, but also cause an attenuated T cell response in sustained immune reactions, at least partially through type I IFN-mediated PD-1 transcription. Based on this idea, we demonstrate that IFN-? administration in combination with PD-1 blockade in tumor-bearing mice effectively augments the antitumor immunity, and we propose this as a novel and rational approach for cancer immunotherapy.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1550-6606
pubmed:author
pubmed:issnType
Electronic
pubmed:day
1
pubmed:volume
186
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2772-9
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:21263073-Animals, pubmed-meshheading:21263073-Antigens, Surface, pubmed-meshheading:21263073-Apoptosis Regulatory Proteins, pubmed-meshheading:21263073-Cell Line, pubmed-meshheading:21263073-Cell Line, Tumor, pubmed-meshheading:21263073-Cells, Cultured, pubmed-meshheading:21263073-Humans, pubmed-meshheading:21263073-Immunity, Cellular, pubmed-meshheading:21263073-Interferon-Stimulated Gene Factor 3, gamma Subunit, pubmed-meshheading:21263073-Interferon-alpha, pubmed-meshheading:21263073-Mice, pubmed-meshheading:21263073-Mice, Inbred BALB C, pubmed-meshheading:21263073-Mice, Inbred C57BL, pubmed-meshheading:21263073-Mice, Knockout, pubmed-meshheading:21263073-Mice, Transgenic, pubmed-meshheading:21263073-Programmed Cell Death 1 Receptor, pubmed-meshheading:21263073-Receptors, Antigen, T-Cell, pubmed-meshheading:21263073-Regulatory Elements, Transcriptional, pubmed-meshheading:21263073-Signal Transduction, pubmed-meshheading:21263073-T-Lymphocyte Subsets, pubmed-meshheading:21263073-Transcription, Genetic
pubmed:year
2011
pubmed:articleTitle
IFN-? directly promotes programmed cell death-1 transcription and limits the duration of T cell-mediated immunity.
pubmed:affiliation
Department of Immunology and Genomic Medicine, Graduate School of Medicine, Kyoto University, Yoshida-konoe, Sakyo-Ku, Kyoto 606-8501, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't